Published on in CHOP in the Media
CHOP’s Food Allergy Center was one of the research sites that helped test and develop the new drug
The U.S. Food & Drug Administration (FDA) announced the approval of PalforziaTM, a first-of-its-kind treatment for peanut allergies. Doctors and researchers from The Allergy Program at Children’s Hospital of Philadelphia (CHOP) helped test and develop the breakthrough drug.
Jonathan Spergel, MD, PhD, Section Chief of CHOP's Food Allergy Center, and Terri F. Brown-Whitehorn, MD, attending physician in the Food Allergy Center, spoke with media about the research that led up to the FDA approval and how oral immunotherapy can help children with peanut allergies.